
Transplant Diagnostics Market By Product & Service (Instruments and Reagents & Consumables), By Screening Type (Pre-Transplant and Post-Transplant), By End User (Kidney, Liver, Heart, Lung, and Pancreas), Regional Outlook– Global Forecast up to 2030
Description
We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary methods for qualitative market assessments and market segmentation are top-down and bottom-up techniques. We take pride in our ability to use data triangulation to examine the market from three key angles: primary data mining, a specific statistical model and framework, and primary source data validation.
We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.
We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.
To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.
Transplant Diagnostics Market based on Product & Service:
The rapid modernization and automation of diagnostic laboratories, the rise in the number of organ transplant procedures, and the outsourcing of research and development activities by pharmaceutical and biotechnology companies to independent reference laboratories are additional factors contributing to this segment's large share.
Pre- and post-transplant screening are included in the market segmentation for transplant diagnostics based on the type of screening. Pre-transplant revenue accounted for roughly 60–64 percent of the transplant diagnostics market in 2021, giving it the lion's share of the market. Pre-transplantation analysis techniques like these are used to make sure things run smoothly and safely. The adoption of technologically improved instruments at a rapid pace and rising physician awareness are two factors that are anticipated to propel growth in the upcoming years. Additionally, a growing elderly population that is more vulnerable to many chronic illnesses as a result of weakened immunity is one of the main causes driving the pre-transplant diagnostics market expansion for diagnostic applications.
Organ types that are included in the market segmentation of transplant diagnostics include kidney, liver, heart, lung, and pancreas. In 2021, the kidney segment accounted for the largest proportion of market revenue. The market is expected to increase in segments due to the rising number of kidney transplant surgeries and the government rules that encourage organ donations in key healthcare markets. The market for serological transplant diagnostics is seeing an increase in the use of kidney and liver transplants due to the growing prevalence of renal and liver failure among the elderly population. in particular in people who have long-term illnesses. According to publications titled Chronic Kidney Disease in India released by the American Society of Nephrology, the prevalence of CKD in India varies from 1% to 13%.
We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.
We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.
To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.
Transplant Diagnostics Market based on Product & Service:
- Instruments
- Reagents & Consumables
- Pre-Transplant
- Post-Transplant
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The rapid modernization and automation of diagnostic laboratories, the rise in the number of organ transplant procedures, and the outsourcing of research and development activities by pharmaceutical and biotechnology companies to independent reference laboratories are additional factors contributing to this segment's large share.
Pre- and post-transplant screening are included in the market segmentation for transplant diagnostics based on the type of screening. Pre-transplant revenue accounted for roughly 60–64 percent of the transplant diagnostics market in 2021, giving it the lion's share of the market. Pre-transplantation analysis techniques like these are used to make sure things run smoothly and safely. The adoption of technologically improved instruments at a rapid pace and rising physician awareness are two factors that are anticipated to propel growth in the upcoming years. Additionally, a growing elderly population that is more vulnerable to many chronic illnesses as a result of weakened immunity is one of the main causes driving the pre-transplant diagnostics market expansion for diagnostic applications.
Organ types that are included in the market segmentation of transplant diagnostics include kidney, liver, heart, lung, and pancreas. In 2021, the kidney segment accounted for the largest proportion of market revenue. The market is expected to increase in segments due to the rising number of kidney transplant surgeries and the government rules that encourage organ donations in key healthcare markets. The market for serological transplant diagnostics is seeing an increase in the use of kidney and liver transplants due to the growing prevalence of renal and liver failure among the elderly population. in particular in people who have long-term illnesses. According to publications titled Chronic Kidney Disease in India released by the American Society of Nephrology, the prevalence of CKD in India varies from 1% to 13%.
- This report illustrates the most vital attributes of the Transplant Diagnostics Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Transplant Diagnostics Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Transplant Diagnostics Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Transplant Diagnostics Market.
Table of Contents
145 Pages
- 1. Executive Summary
- 2. Industry Outlook
- 2.1. Industry Overview
- 2.2. Industry Trends
- 3. Market Snapshot
- 3.1. Market Definition
- 3.2. Market Outlook
- 3.2.1. Porter Five Forces
- 3.3. Related Markets
- 4. Market characteristics
- 4.1. Market Overview
- 4.2. Market Segmentation
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. DRO - Impact Analysis
- 5. Product & Service: Market Size & Analysis
- 5.1. Overview
- 5.2. Instruments
- 5.3. Reagents & Consumables
- 6. Screening Type: Market Size & Analysis
- 6.1. Overview
- 6.2. Pre-Transplant
- 6.3. Post-Transplant
- 7. Organ Type: Market Size & Analysis
- 7.1. Overview
- 7.2. Kidney
- 7.3. Liver
- 7.4. Heart
- 7.5. Lung
- 7.6. Pancreas
- 8. Geography: Market Size & Analysis
- 8.1. Overview
- 8.2. North America (U.S., Mexico, Canada)
- 8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
- 8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
- 8.5. Latin America (Brazil, Argentina)
- 8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
- 9. Competitive Landscape
- 9.1. Competitor Comparison Analysis
- 9.2. Market Developments
- 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
- 9.2.2. Product Launches and execution
- 10. Vendor Profiles
- 10.1. HOLOGIC, INC. (U.S.)
- 10.1.1. Overview
- 10.1.2. Financial Overview
- 10.1.3. Product Offerings
- 10.1.4. Developments
- 10.1.5. Business Strategy
- 10.2. BIOFORTUNA LIMITED (U.K.)
- 10.2.1. Overview
- 10.2.2. Financial Overview
- 10.2.3. Product Offerings
- 10.2.4. Developments
- 10.2.5. Business Strategy
- 10.3. TAKARA BIO INC. (JAPAN)
- 10.3.1. Overview
- 10.3.2. Financial Overview
- 10.3.3. Product Offerings
- 10.3.4. Developments
- 10.3.5. Business Strategy
- 10.4. ABBOTT (U.S.)
- 10.4.1. Overview
- 10.4.2. Financial Overview
- 10.4.3. Product Offerings
- 10.4.4. Developments
- 10.4.5. Business Strategy
- 10.5. DIAGNÓSTICA LONGWOOD SL (SPAIN)
- 10.5.1. Overview
- 10.5.2. Financial Overview
- 10.5.3. Product Offerings
- 10.5.4. Developments
- 10.5.5. Business Strategy
- 10.6. ADAPTIVE BIOTECHNOLOGIES (U.S.)
- 10.6.1. Overview
- 10.6.2. Financial Overview
- 10.6.3. Product Offerings
- 10.6.4. Developments
- 10.6.5. Business Strategy
- 10.7. NANOSTRING TECHNOLOGIES, INC.(U.S.)
- 10.7.1. Overview
- 10.7.2. Financial Overview
- 10.7.3. Product Offerings
- 10.7.4. Developments
- 10.7.5. Business Strategy
- 10.8. ARQUER DIAGNOSTICS LTD (U.K.)
- 10.8.1. Overview
- 10.8.2. Financial Overview
- 10.8.3. Product Offerings
- 10.8.4. Developments
- 10.8.5. Business Strategy
- 10.9. F. ALTONA DIAGNOSTICS GMBH (GERMANY)
- 10.9.1. Overview
- 10.9.2. Financial Overview
- 10.9.3. Product Offerings
- 10.9.4. Developments
- 10.9.5. Business Strategy
- 10.10. ELITECHGROUP (FRANCE)
- 10.10.1. Overview
- 10.10.2. Financial Overview
- 10.10.3. Product Offerings
- 10.10.4. Developments
- 10.10.5. Business Strategy
- 11. Analyst Opinion
- 12. Annexure
- 12.1. Report Scope
- 12.2. Market Definitions
- 12.3. Research Methodology
- 12.3.1. Data Collation and In-house Estimation
- 12.3.2. Market Triangulation
- 12.3.3. Forecasting
- 12.4. Report Assumptions
- 12.5. Declarations
- 12.6. Stakeholders
- 12.7. Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.